Tags: Drug.

Aztreonam (trade names Azactam injection Cayston inhalation) is a synthetic monocyclic beta-lactam antibiotic (a monobactam) with the nucleus based on a simpler monobactam isolated from Chromobacterium violaceum. It was approved by the U.S. Food and Drug Administration (FDA) in 1986. It is resistant to some beta-lactamases but is inactivated by extended-spectrum beta-lactamases.

Aztreonam_structure.svg
ATC prefix
J01
ATC suffix
DF01
Bioavailability
100.0
CAS number
78110-38-0
ChEBI
161680
DrugBank
DB00355
FDA UNII code
G2B4VE5GH8
IUPAC name
2-([(1Z)-1-(2-amino-13-thiazol-4-yl) -2- [(2S3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino -2- oxoethylidene]aminooxy)-2-methylpropanoic acid
PubChem
54116

Loading...

This page contains content from the copyrighted Wikipedia article "Aztreonam"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.